307 related articles for article (PubMed ID: 32643284)
1. Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis.
Sun Y; Zhu Y; Liu X; Chai Y; Xu J
Cell Prolif; 2020 Aug; 53(8):e12866. PubMed ID: 32643284
[TBL] [Abstract][Full Text] [Related]
2. Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway.
Zhang M; Li Y; Rao P; Huang K; Luo D; Cai X; Xiao J
Cell Prolif; 2018 Oct; 51(5):e12471. PubMed ID: 30014569
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin 2 improves bone regeneration in type 1 diabetic rats by restoring imbalanced macrophage polarization and impaired osteogenesis.
Wang F; Kong L; Wang W; Shi L; Wang M; Chai Y; Xu J; Kang Q
Stem Cell Res Ther; 2021 May; 12(1):288. PubMed ID: 33985585
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal - an advanced glycation end products (AGEs) precursor - Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE).
Waqas K; Muller M; Koedam M; El Kadi Y; Zillikens MC; van der Eerden BCJ
Bone; 2022 Nov; 164():116526. PubMed ID: 35995334
[TBL] [Abstract][Full Text] [Related]
5. Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway.
Zhu Y; Wang Y; Jia Y; Xu J; Chai Y
Stem Cell Res Ther; 2019 Jan; 10(1):37. PubMed ID: 30670092
[TBL] [Abstract][Full Text] [Related]
6. Morroniside-mediated mitigation of stem cell and endothelial cell dysfunction for the therapy of glucocorticoid-induced osteonecrosis of the femoral head.
Jiang H; Wang W; Mao Y; Jiang L; Yu J; Zhu X; Fu H; Lin Z; Shen H; Pan X; Xue X
Int Immunopharmacol; 2024 Jan; 127():111421. PubMed ID: 38157694
[TBL] [Abstract][Full Text] [Related]
7. Endothelial progenitor cells improve the therapeutic effect of mesenchymal stem cell sheets on irradiated bone defect repair in a rat model.
Liu H; Jiao Y; Zhou W; Bai S; Feng Z; Dong Y; Liu Q; Feng X; Zhao Y
J Transl Med; 2018 May; 16(1):137. PubMed ID: 29788957
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway.
Cheng YZ; Yang SL; Wang JY; Ye M; Zhuo XY; Wang LT; Chen H; Zhang H; Yang L
Life Sci; 2018 Jul; 205():184-192. PubMed ID: 29702126
[TBL] [Abstract][Full Text] [Related]
9. Calcium phytate reverses high glucose-inhibited osteogenesis of BMSCs via the MAPK/JNK pathway.
Lv J; Wang Q; Liu D; Chu CH; Zhou H; Li G; Wu J; Cai K; Tang C
Oral Dis; 2024 Apr; 30(3):1379-1391. PubMed ID: 37103891
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N
Zhou J; Zhu Y; Ai D; Zhou M; Li H; Li G; Zheng L; Song J
J Transl Med; 2023 Nov; 21(1):781. PubMed ID: 37925419
[TBL] [Abstract][Full Text] [Related]
12. MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway.
Hu BT; Chen WZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7156-7163. PubMed ID: 30468456
[TBL] [Abstract][Full Text] [Related]
13. miR‑488 negatively regulates osteogenic differentiation of bone marrow mesenchymal stem cells induced by psoralen by targeting Runx2.
Huang Y; Hou Q; Su H; Chen D; Luo Y; Jiang T
Mol Med Rep; 2019 Oct; 20(4):3746-3754. PubMed ID: 31485621
[TBL] [Abstract][Full Text] [Related]
14. Effect of morroniside on glomerular mesangial cells through AGE-RAGE pathway.
Lv G; Lv X; Tao Y; Xu H
Hum Cell; 2016 Oct; 29(4):148-54. PubMed ID: 27068830
[TBL] [Abstract][Full Text] [Related]
15. Osteoinductive effects of glyceollins on adult mesenchymal stromal/stem cells from adipose tissue and bone marrow.
Bateman ME; Strong AL; Hunter RS; Bratton MR; Komati R; Sridhar J; Riley KE; Wang G; Hayes DJ; Boue SM; Burow ME; Bunnell BA
Phytomedicine; 2017 Apr; 27():39-51. PubMed ID: 28314478
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow mesenchymal stem cells modulated the inflammatory response by regulating the expression of IL-4 and RAGE products in the rats with MODS].
Zhou X; Xiu G; Zhu Y; Chen X; Xiong W; Pan X; Sun J; Ling B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Apr; 29(4):294-299. PubMed ID: 28420460
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt/β-catenin signalling pathway via DNA methylation.
Li Y; Wang L; Zhang M; Huang K; Yao Z; Rao P; Cai X; Xiao J
Cell Prolif; 2020 Jun; 53(6):e12834. PubMed ID: 32468637
[TBL] [Abstract][Full Text] [Related]
18. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
Xiu G; Xiong W; Yin Y; Chen X; Liu P; Sun J; Ling B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):830-835. PubMed ID: 30309407
[TBL] [Abstract][Full Text] [Related]
19. The use of SHP-2 gene transduced bone marrow mesenchymal stem cells to promote osteogenic differentiation and bone defect repair in rat.
Fan D; Liu S; Jiang S; Li Z; Mo X; Ruan H; Zou GM; Fan C
J Biomed Mater Res A; 2016 Aug; 104(8):1871-81. PubMed ID: 26999642
[TBL] [Abstract][Full Text] [Related]
20. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
